Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-13

Clinical Trial Update: Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the duration of immunity after one dose of yellow fever vaccine in adults and children (Paraiba Study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Yellow Fever Vaccine, Immunity | Phase 4 | Status: ACTIVE_NOT_RECRUITING